11:09 AM EDT, 04/12/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower Friday morning, falling 0.66% to 1,356.48 on the S&P Europe Select ADR Index. The index is poised to close the week down nearly 1.7%.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company DBV Technologies ( DBVT ) , which rose 2.3% and 2.1% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and oil and gas company Eni (E), which were up 2% and 1.7% respectively.

The decliners from continental Europe were led by biopharmaceutical company Calliditas Therapeutics ( CALT ) and biotech firm Biophytis ( BPTS ) , which fell 6.6% and 4.5% respectively. They were followed by internet browser company Opera (OPRA) and financial services company ING (ING), which lost 4.3% and 4.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Trinity Biotech ( TRIB ) , which rose 6.8% and 2.2% respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and oil and gas giant BP (BP), which were up 1.7% each.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Biodexa Pharmaceuticals ( BDRX ) , which dropped 6.2% and 4.9% respectively. They were followed by biopharmaceutical companies TC Biopharm ( TCBP ) and Amarin ( AMRN ) , which lost 3.5% and 3.3% respectively.